4//SEC Filing
Horvath Susan 4
Accession 0001437749-23-002263
CIK 0001029125other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:36 PM ET
Size
6.9 KB
Accession
0001437749-23-002263
Insider Transaction Report
Form 4
Horvath Susan
V.P. of Finance & CFO
Transactions
- Purchase
Warrants (right to buy)
2023-01-30+8,888→ 8,888 totalExercise: $2.75From: 2023-01-30Exp: 2028-01-30→ Common Stock (8,888 underlying) - Purchase
Common Stock
2023-01-30+4,444→ 17,880 total
Footnotes (2)
- [F1]Reported securities purchased as one share of common stock and one warrant to purchase two shares of common stock for a combined price of $2.25 per share and warrant.
- [F2]On or after March 1, 2023, holder may elect an "alternative cashless exercise" pursuant to which they would receive an aggregate number of shares of common stock equal to 75% of the aggregate number of shares that would be issuable upon a cash exercise.
Documents
Issuer
Panbela Therapeutics, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001322846
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:36 PM ET
- Size
- 6.9 KB